SCHEMBL29182

SCHEMBL29182

Nc1cc(C2CCSC(O)(O)C2)nc2c(-c3ccc(-c4ccccc4)nc3)cnn12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 13/20 0.52
CCNA2 P20248 11/20 0.52
CDK2 P24941 11/20 0.52
CCNA1 P78396 11/20 0.52
MEN1 O00255 2/20 0.43
NPC1 O15118 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43
GFER P55789 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MTOR P42345 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15026293 0.82 CHEK1 (0.64) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL2704383 0.81 MTOR (0.38) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL21483 0.80 CHEK1 (0.56) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL17850056 0.80 CHEK1 (0.56) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL15007512 0.80 CHEK1 (0.56) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL20332 0.80 CHEK1 (0.52) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL12460566 0.79 CHEK1 (0.57) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL14246610 0.79 CHEK1 (0.57) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL14245841 0.79 CHEK1 (0.57) CHEK1CCNA2CDK2CCNA1MEN1
SCHEMBL15007509 0.79 CHEK1 (0.55) CHEK1CCNA2CDK2CCNA1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608668-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN Merck Sharp & Dohme Corp. (US) 2013-07-03 EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed